16.51 -1.54 (-8.53%) | 01-03 16:00 | |||||||||||||
|
|
Short term | ||||
Mid term | ||||
Targets | 6-month : | 6.56 | 1-year : | 7.66 |
Resists | First : | 5.61 | Second : | 6.56 |
Pivot price | 4.82 | |||
Supports | First : | 4.71 | Second : | 4.15 |
MAs | MA(5) : | 5.14 | MA(20) : | 4.73 |
MA(100) : | 6.03 | MA(250) : | 8.13 | |
MACD | MACD : | -0.1 | Signal : | -0.3 |
%K %D | K(14,3) : | 92.8 | D(3) : | 83 |
RSI | RSI(14): 57.2 | |||
52-week | High : | 17.51 | Low : | 4.15 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ LTHM ] has closed It is unclear right now based on current values. 52.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 21 bars. This is a sign that the market may be about to initiate a new trend.
If tomorrow: | Open lower | Open higher |
High: | 5.62 - 5.64 | 5.64 - 5.66 |
Low: | 5.29 - 5.32 | 5.32 - 5.34 |
Close: | 5.49 - 5.53 | 5.53 - 5.56 |
Livent Corporation manufactures and sells performance lithium compounds primarily used in lithium-based batteries, specialty polymers, and chemical synthesis applications in North America, Latin America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers lithium compounds for use in applications that have specific performance requirements, including battery-grade lithium hydroxide for use in high performance lithium-ion batteries; and butyllithium, which is used in the production of polymers and pharmaceutical products, as well as a range of specialty lithium compounds, including high purity lithium metal, which is used in non-rechargeable batteries and the production of lightweight materials for aerospace applications. It also provides lithium phosphate, pharmaceutical-grade lithium carbonate, high purity lithium chloride, and specialty organics; and lithium carbonate and lithium chloride for use as feedstock in the process of producing performance lithium compounds. The company was incorporated in 2018 and is headquartered in Philadelphia, Pennsylvania.
Thu, 04 Jan 2024
Arcadium Lithium Announces Completion of Merger of Equals between Allkem and Livent USA - English - APAC ... - PR Newswire
Tue, 19 Dec 2023
Allkem shareholders approve $10.6 billion Livent lithium merger - Reuters
Tue, 19 Dec 2023
Livent and Allkem Shareholders Approve Merger of Equals - PR Newswire
Thu, 14 Dec 2023
LIVENT INVESTS IN ILiAD TECHNOLOGIES TO STRENGTHEN LEADERSHIP IN DIRECT LITHIUM EXTRACTION ... - PR Newswire
Mon, 11 Dec 2023
Is Trending Stock Livent Corporation (LTHM) a Buy Now? - Yahoo Finance
Tue, 28 Nov 2023
Livent Corporation (LTHM) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Outperform |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
Exchange:
NYSE
|
|
Sector:
Basic Materials
|
|
Industry:
Chemicals - Specialty
|
|
Shares Out | 180 (M) |
Shares Float | 179 (M) |
Held by Insiders | 0 (%) |
Held by Institutions | 0 (%) |
Shares Short | 25,640 (K) |
Shares Short P.Month | 26,330 (K) |
EPS | 1.79 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 9.68 |
Profit Margin | 40.7 % |
Operating Margin | 41.8 % |
Return on Assets (ttm) | 12.6 % |
Return on Equity (ttm) | 24.2 % |
Qtrly Rev. Growth | -8.7 % |
Gross Profit (p.s.) | 2.21 |
Sales Per Share | 5.11 |
EBITDA (p.s.) | 2.63 |
Qtrly Earnings Growth | 13.5 % |
Operating Cash Flow | 388 (M) |
Levered Free Cash Flow | -47 (M) |
PE Ratio | 3.07 |
PEG Ratio | 0.1 |
Price to Book value | 0.57 |
Price to Sales | 1.08 |
Price to Cash Flow | 2.56 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |